推动健康转型:大制药公司的创新实验室革命
Galo Peralta1, Blanca Sánchez2
1Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain. galo.peralta@idival.org.
Health research policy and systems
|October 24, 2025
概括
制药公司越来越多地使用创新实验室来推动医疗保健转型. 多中心实验室擅长外部合作和创业精神,而单中心实验室专注于内部增长和早期研究.
科学领域:
- 制药创新和医疗保健转型
- 制药行业中的组织策略
- 数字健康解决方案和远程患者监控
背景情况:
- 制药公司正在从封闭的研发转向开放的协作创新生态系统.
- 创新实验室是加速医疗保健解决方案开发和采用的关键基础设施.
- 对行业主导的制药创新实验室的系统理解是有限的.
研究的目的:
- 描述制药创新实验室的结构,重点,活动和产出.
- 在创新实验室的不同组织模式中识别模式和差异.
- 为制药创新基础设施的战略发展提供信息.
主要方法:
- 在PubMed的结构化文献评论和20家顶级制药公司的创新实验室的映射.
- 从同行评审的出版物,企业报告和灰色文献收集数据.
- 基于数字导向,地理结构,活动,利益相关方参与和成果的实验室分析.
主要成果:
- 分析了来自14家公司的102个创新中心,大多数都以数字化为重点 (数字健康,远程监控).
- 合作率高 (98%),主要与大学 (92%) 和其他行业 (65%) 合作.
- 与专注于内部能力建设和早期研究的单中心实验室相比,多中心实验室显示出更大的外部合作,创业支持和产出 (专利,分拆).
结论:
- 制药创新实验室整合了科学,技术和创业方法来改变医疗保健.
- 多中心和单中心模式为创新提供了互补的优势.
- 两种模式的平衡可以最大限度地提高制药创新基础设施的影响.
相关概念视频
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Drug Products: Biologics, Biosimilars and Interchangeables
230
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
230
Drug Administration and Therapy Phases: Overview
1.3K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.3K


